Opportunities and challenges in the search for new medicinesIn Lilly’s latest offering, Douglas K. Norman discusses how the rate of research and development of innovative medicines Share XOpportunities and challenges in the search for new medicineshttps://pharmaphorum.com/views-and-analysis/opportunities-and-challenges-in-the-search-for-new-medicines/
Perspectives on oncology personalised healthcare: Ruth March (transcript)In the final run up to publication of our first round table video debate on advances in personalised Share XPerspectives on oncology personalised healthcare: Ruth March (transcript)https://pharmaphorum.com/views-and-analysis/perspectives-on-oncology-personalised-healthcare-ruth-march-transcript/
Bringing pharma sales training to life with digital technologyIn the final part of this series on how digital engagement techniques play a vital role in pharma Share XBringing pharma sales training to life with digital technologyhttps://pharmaphorum.com/views-and-analysis/bringing-pharma-sales-training-to-life-with-digital-technology/
Diabetes in the Middle East and North Africa: a high growth pharmaceutical market receptive to innovationCarolyn Gauntlett discusses the growing global prevalence of diabetes, but more specifically in the Middle East and North Share XDiabetes in the Middle East and North Africa: a high growth pharmaceutical market receptive to innovationhttps://pharmaphorum.com/views-and-analysis/diabetes-in-the-middle-east-and-north-africa-a-high-growth-pharmaceutical-market-receptive-to-innovation/
Emergence and evolution of alliance managementAs R&D collaborations have grown in volume and complexity over the last decade, so has widespread adoption of Share XEmergence and evolution of alliance managementhttps://pharmaphorum.com/views-and-analysis/emergence-and-evolution-of-alliance-management/
A history of NovartisNovartis is one of the world’s top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland’s Share XA history of Novartishttps://pharmaphorum.com/articles/a-history-of-novartis/
Transforming big pharmaPaul Tunnah interviews John Ansell, author of ‘Transforming Big Pharma – Assessing the Strategic Alternatives’ on what inspired Share XTransforming big pharmahttps://pharmaphorum.com/views-and-analysis/paul-tunnah-interviews-john-ansell/
A digital future for the life sciences industrySunil Rao, global managing director of technology for Accenture’s Life Sciences’ practice, explores the role of digital in Share XA digital future for the life sciences industryhttps://pharmaphorum.com/views-and-analysis/a-digital-future-for-the-life-sciences-industry/
Do pharma meetings have a future?Following the second annual Healthcare Meetings Forum, held in London, Paul Tunnah reviews the mood of the pharmaceutical Share XDo pharma meetings have a future?https://pharmaphorum.com/views-and-analysis/do-pharma-meetings-have-a-future/
